Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium.
Asgeirsdóttir SA, Kamps JA, Bakker HI, Zwiers PJ, Heeringa P, van der Weide K, van Goor H, Petersen AH, Morselt H, Moorlag HE, Steenbergen E, Kallenberg CG, Molema G.
Asgeirsdóttir SA, et al. Among authors: molema g.
Mol Pharmacol. 2007 Jul;72(1):121-31. doi: 10.1124/mol.107.034140. Epub 2007 Apr 23.
Mol Pharmacol. 2007.
PMID: 17452496